Daily Cosmetic Research Analysis
Today’s top cosmetic-related studies include an RCT showing ultrasonic scalpel plus single-session photodynamic therapy outperforms trichloroacetic acid for condyloma with superior cosmetic outcomes and zero 18-month recurrence. High-resolution ultrasonography maps periorbital soft-tissue layers to guide safer aesthetic procedures, and a split-side double-blind RCT supports 0.025% tretinoin for axillary hyperpigmentation in acanthosis nigricans with meaningful pigment reduction and mild adverse
Summary
Today’s top cosmetic-related studies include an RCT showing ultrasonic scalpel plus single-session photodynamic therapy outperforms trichloroacetic acid for condyloma with superior cosmetic outcomes and zero 18-month recurrence. High-resolution ultrasonography maps periorbital soft-tissue layers to guide safer aesthetic procedures, and a split-side double-blind RCT supports 0.025% tretinoin for axillary hyperpigmentation in acanthosis nigricans with meaningful pigment reduction and mild adverse effects.
Research Themes
- Evidence-based cosmetic interventions and outcomes
- Imaging-guided precision in aesthetic procedures
- Management of pigmentary disorders with accessible therapies
Selected Articles
1. Comparative Efficacy of Ultrasonic Scalpel Surgery With Photodynamic Therapy Versus Trichloroacetic Acid Application in Treating HPV-Related Condyloma Acuminata: A Randomized Clinical Trial.
In this RCT, ultrasonic scalpel excision followed by single-session PDT outperformed 80% TAA for condyloma acuminata: fewer sessions, better cosmetic results, and 0% recurrence at 18 months versus 33.3% with TAA. Patient-reported PDT pain limited adherence, highlighting a need for protocol optimization.
Impact: Provides randomized evidence for a combined surgical–PDT approach that may replace or complement TCA in condyloma management with superior cosmetic and recurrence outcomes.
Clinical Implications: Consider US+PDT as a first-line or second-line option for condyloma acuminata when cosmetic outcomes and recurrence reduction are priorities. Implement analgesia/sedation strategies and optimize PDT protocols to improve tolerability and adherence.
Key Findings
- US+PDT required fewer treatment sessions than 80% TAA monotherapy.
- Cosmetic outcomes were superior in the US+PDT group.
- Recurrence at 18 months was 0% with US+PDT versus 33.3% with TAA.
- Pain during PDT limited adherence and completion rates.
Methodological Strengths
- Randomized clinical trial design with an active standard-of-care comparator (80% TAA).
- Long follow-up of 18 months capturing clinically meaningful recurrence outcomes.
Limitations
- Sample size and detailed CONSORT elements are not specified in the abstract.
- Potential lack of blinding and pain-related discontinuations may introduce bias.
Future Directions: Conduct larger multicenter, blinded RCTs, refine PDT parameters and analgesic regimens to improve tolerability, and assess cost-effectiveness and quality-of-life outcomes.
Human papillomavirus (HPV) infections rank as the most prevalent sexually transmitted infections globally. The Brazilian Ministry of Health recommends the topical use of 70%-90% trichloroacetic acid (TAA) for treating condyloma acuminata, yet this method suffers from a high recurrence rate of 36% and requires roughly six applications. Topical photodynamic therapy (PDT) has shown effectiveness in targeting subclinical lesions, but it also necessitates multiple sessions for complete lesion clearance. This randomized clinical trial evaluates the efficacy of 80% TAA monotherapy against a combined approach of ultrasonic scalpel excision followed by a single PDT session (US + PDT). The US + PDT group required fewer treatment sessions, exhibited superior cosmetic outcomes, and reported zero lesion recurrence during an 18-month follow-up, in contrast to the TAA group's recurrence rate of 33.3%. Notwithstanding, patient-reported pain during PDT application emerged as a significant barrier, affecting treatment adherence and completion rates. Innovating new PDT protocols could potentially address this challenge, enhancing patient compliance and therapeutic success.
2. Topographic Analysis of the Periorbital Region Including Orbicularis Oculi Muscle Based on Ultrasonography Interpretation.
In 52 healthy volunteers, periorbital ultrasonography quantified layer thicknesses: orbicularis oculi averaged 1.56 mm, was thickest at points VI–VII, and lay at a mean depth of 1.63 mm. These benchmarks can guide ultrasound-assisted injections and procedural planning to improve safety and accuracy in aesthetic treatments.
Impact: Provides quantitative anatomical benchmarks for the periorbital region that can directly reduce complications and improve precision in cosmetic procedures.
Clinical Implications: Use point-specific thickness/depth data to select injection planes, doses, and needle depths for botulinum toxin and fillers; adopt ultrasonography to visualize target layers and avoid critical structures.
Key Findings
- Mean orbicularis oculi thickness was 1.56 ± 0.45 mm (range 1.03–2.31 mm).
- Greatest thickness at points VII (2.31 ± 0.68 mm) and VI (2.15 ± 0.48 mm).
- Mean depth of orbicularis oculi was 1.63 ± 0.62 mm (range 0.88–2.80 mm), most superficial at point VII.
- Standardized ultrasonography protocol using linear transducers and ImageJ measurements across nine reference points.
Methodological Strengths
- Prospective standardized imaging across predefined landmarks with a consistent transducer and analysis workflow.
- Objective quantification using ImageJ with clearly reported thickness and depth metrics.
Limitations
- Young, healthy cohort (mean age 28.4 years) may limit generalizability to older or diverse populations.
- No inter-rater reliability metrics or direct linkage to procedural outcomes.
Future Directions: Build age-, sex-, and ethnicity-stratified atlases, validate inter-operator reliability, and correlate ultrasound metrics with complication rates in aesthetic procedures.
OBJECTIVE: Ultrasonographic examination is easy, fast, safe, and used in various fields; however, its application to the facial area has been limited. Complex anatomical structures are mixed within thin, soft tissues in the facial region; therefore, understanding their structural characteristics is crucial. This study aimed to use ultrasonography to obtain information on the layered structure and soft tissue thickness of the eye area around the orbicularis oculi muscle and provide guidance for clinical practice. METHODS: Healthy volunteers (33
3. Assessing the efficacy and safety profiles of 0.025% tretinoin in treating axillary hyperpigmentation with acanthosis nigricans: a randomized double-blinded study.
A double-blind, split-side RCT (n=20) showed 0.025% tretinoin significantly lightened axillary hyperpigmentation in AN versus base cream (mean M-index reduction 28.05% vs 6.55%; p<0.001), with 75% achieving >75% improvement by IGE and PGE. Adverse effects were mild; partial relapse occurred after stopping.
Impact: Provides controlled evidence for a low-cost, widely available therapy for a cosmetically significant condition with limited prior data.
Clinical Implications: Consider 0.025% tretinoin for axillary hyperpigmentation in AN, with counseling on mild irritation and the likelihood of partial relapse after cessation; maintenance or step-down regimens may be needed.
Key Findings
- At week 8, mean melanin index reduction was 28.05% ± 12.20% with tretinoin vs 6.55% ± 12.66% with control (p<0.001).
- 75% of tretinoin-treated sides achieved >75% improvement by IGE and PGE at week 8.
- Adverse effects were mild (erythema, peeling, itching).
- Partial recurrence of hyperpigmentation occurred after treatment cessation.
Methodological Strengths
- Randomized, double-blinded, intra-individual split-side design minimizing intersubject variability.
- Objective pigment quantification using narrowband reflectance spectrophotometry (melanin index).
Limitations
- Small sample size (n=20) and short follow-up with a 4-week cessation phase.
- Relapse after stopping suggests need for longer-term maintenance strategies.
Future Directions: Larger, longer-duration trials to define optimal dosing, maintenance strategies, combination regimens, and long-term safety in diverse AN populations.
Acanthosis nigricans (AN) is a dermatological condition, marked by hyperpigmentation and skin thickening, frequently affecting body folds like the axillae. Treatment options for axillary hyperpigmentation remain underexplored. This study evaluated the efficacy of 0.025% tretinoin cream in treating axillary hyperpigmentation associated with AN. In a randomized, intra-individual, split-side design study, participants applied 0.025% tretinoin cream on one axilla and a cream-based on the other. The study spanned 12 weeks, with topical application for the first 8 weeks, followed by a 4-week cessation period. Efficacy was measured using the melanin (M) index via narrowband reflectance spectrophotometry. Overall success was evaluated through investigator- and participant-global evaluation (IGE and PGE) scales, with adverse effects monitored. Twenty participants completed the study. The 0.025% tretinoin cream significantly reduced hyperpigmentation compared to the control (p < 0.001). By week 8, the mean M index reduction with tretinoin was 28.05%±12.20%, versus 6.55%±12.66% with the control. Hyperpigmentation reappeared partially after treatment cessation. By week 8, 75% of participants in the tretinoin group achieved more than 75% improvement in IGE, compared to 35% in the cream-based group. Similarly, 75% of the tretinoin group reported more than 75% improvement in PGE, whereas only 15% of the cream-based group achieved more than 50% improvement. Adverse effects were mild and included slight erythema, peeling, and itching. The 0.025% tretinoin cream significantly improved AN patients' axillary hyperpigmentation, demonstrating a safe and effective treatment option with minimal side effects.